This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Despite this dire need, there is wide variability in such processes, including the timing, setting, tools utilized and interpretation of the results, according to new research.
The world’s top nuclear medicine societies have issued international guidelines on the role of PET/CT in patients with invasive ductal carcinoma breast cancer, with the document released May 14 in the European Journal of Nuclear Medicine and Molecular Imaging. Experts from the European Association of Nuclear Medicine (EANM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) said that despite much literature about the role of F-18 FDG-PET/CT in these patients, “there exists no inte
Established guidelines recommend biopsying small tumors of the kidney ahead of any procedure to ablate them. A new study confirms the validity of pursuing another pathway.
Screening for "financial toxicity" (FT) in cancer care could use improvement in the U.S., according to a review published May 16 in the Journal of the American College of Radiology. The term refers to " the objective, subjective, and behavioral patient-level impact of the costs of cancer care," wrote a team led by Nadia Samaha of Johns Hopkins University in Baltimore.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
St. Luke's University Health Network recently launched its region's only accredited radiology residency program in response to booming demand for imaging.
In individuals who have not completed a DEXA scan, head CT conducted for other reasons can offer insight into patients’ frontal bone density, a potential marker of osteoporosis.
242
242
Sign up to get articles personalized to your interests!
Diagnostic Imaging Brief brings together the best content for architecture professionals from the widest variety of industry thought leaders.
In individuals who have not completed a DEXA scan, head CT conducted for other reasons can offer insight into patients’ frontal bone density, a potential marker of osteoporosis.
Imaging and radiology centers are among the least affected hospital services in Ukraine since the beginning of the Russian invasion in 2022, a study published May 17 in JAMA Health Forum found. A team led by Ubydul Haque, PhD, from the Rutgers Global Health Institute in New Brunswick, NJ found that such services have experienced a slight decrease in availability, while services for cancer screening, laboratory testing, and gynecological care, among others, have been the most impacted.
PE sponsors announced or closed about 158 transactions in the first quarter (including five in imaging), a “downward trend even from 2023’s sluggish pace,” Pitchbook reports.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
First completely redesigned mammography platform in over a decade New features reduce patient discomfort and improve user ergonomics Premarket approval application filed for PlatinumTomo 3D portion with new technology Siemens Healthineers has announced the Food and Drug Administration 510(k) clearance of the MAMMOMAT B.brilliant — the first completely redesigned mammography platform in more than 10 years.
In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
From the importance of a strategic approach for maximizing AI’s impact to boosting cross-department efficiency and enabling preventative care, these topics were of keen interest for industry leaders at the recent Modern Healthcare Digital Health Summit. In a fireside chat with journalist Gabriel Perna, Aidoc CEO Elad Walach shared perspective on the evolving landscape of clinical AI.
Reportedly trained on thousands of computed tomography scans, the e-Lung software utilizes machine learning to detect and assess the progression of features associated with interstitial lung diseases.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
milla1cf Fri, 05/17/2024 - 18:41 May 17, 2024 — The Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting found that the noncontrast x-ray pulsatility index (XPI) method to evaluate and monitor pulmonary blood flow could improve clinical efficiency as a screening or diagnostic test, provide substantial financial benefits, and improve patient satisfaction.
Successfully managing construction projects leads to satisfied clients and profits that align with your goals. Yet, two more common reasons for delays that cause construction management failures include project scheduling and time management. By mastering these areas specifically, improving operational management while keeping teams working towards an achievable goal may be possible.
milla1cf Fri, 05/17/2024 - 18:43 May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's ( ASTRO ) 66th Annual Meeting, which will be held at the Walter E. Washington Convention Center in Washington, D.C., September 29 – October 2, 2024. Media registration is available at www.astro.org/annualmeetingpress , and general registration is available at www.astro.org/annualmeeting.
From the importance of a strategic approach for maximizing AI’s impact to boosting cross-department efficiency and enabling preventative care, these topics were of keen interest for industry leaders at the recent Modern Healthcare Digital Health Summit. In a fireside chat with journalist Gabriel Perna, Aidoc CEO Elad Walach shared perspective on the evolving landscape of clinical AI.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Researchers have identified the protein galectin-1 (Gal-1) as a new PET imaging biomarker for ICB therapy, enabling doctors to predict tumor responses before treatment begins.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content